Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07436299

Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation

Sponsor: Oslo University Hospital

View on ClinicalTrials.gov

Summary

Heart failure and atrial fibrillation are two of the most common heart diseases globally. Nearly half of all patients with heart failure also have atrial fibrillation. When heart failure and atrial fibrillation occur together, the risk of hospitalization and premature death increases significantly. However, there is a lack of reliable tools to assess how severely the heart is affected in these patients. This makes it difficult both to establish the correct diagnosis, tailor treatment, and predict who is at greatest risk of hospital admission or death from the disease. One of the most important targets in heart failure is the filling pressure in the left ventricle. When this pressure is high, it means that the heart has difficulty receiving blood, leading to shortness of breath and fluid retention in the body. Today, filling pressure is usually estimated using ultrasound (echocardiography), but the available methods are primarily developed for patients without atrial fibrillation. In patients with both heart failure and atrial fibrillation, the measurements are so uncertain that they cannot be used as a reliable basis for clinical decision-making. In this study, entitled Heart Failure combined with Atrial Fibrillation (HFcAF), the investigators will test new ultrasound methods that combine novel measures of cardiac chamber function with established techniques. Artificial intelligence will be used to identify the most useful combinations of parameters, select cardiac cycles that are best suited for analysis in atrial fibrillation, and automate and optimize the measurements. This approach may provide both more accurate and faster assessments, while also making the methods easier to implement in clinical practice. The aim is to improve the estimation of filling pressure so that it becomes more precise also in patients with atrial fibrillation. The investigators will then examine whether these improved methods can be used to predict which patients are at highest risk of hospitalization or death due to heart failure. The study is designed as a prospective multicenter study, in which patients are recruited from several hospitals in different countries. This will make the results robust and generalizable to a wide range of patient populations. The investigators anticipate that the project will pave the way for better diagnostics and risk stratification in heart failure combined with atrial fibrillation and, in the longer term, contribute to improved guidelines and treatment for a large number of patients. If successful, the project will provide a new tool that can contribute to earlier and more targeted treatment, thereby improving quality of life and prognosis for a large group of patients.

Official title: Novel Technologies to Improve Echocardiographic Estimates of Left Ventricular Filling Pressure in Heart Failure Combined With Atrial Fibrillation: A Prospective Multicenter Study

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

400

Start Date

2026-02

Completion Date

2029-12

Last Updated

2026-03-05

Healthy Volunteers

No

Locations (15)

Cleveland Clinic

Cleveland, Ohio, United States

Methodist DeBakey Heart and Vascular Center

Houston, Texas, United States

Cardiovascular Center Aalst, OLV Clinic, Aalst, Belgium

Aalst, Belgium

Catholic University of Leuven

Leuven, Belgium

Laboratory Signal Processing and Image, Department of Cardiology

Rennes, France

Service de Cardiologie, Hôpitaux Universitaires de Strasbourg

Strasbourg, France

Nagoya City University Graduate School of Medical Sciences

Nagoya, Aichi-ken, Japan

Ehime University

Tōon, Ehime, Japan

University of Auckland

Auckland, Auckland, New Zealand

Division of Cardiovascular & Pulmonary Diseases, Oslo University Hospital

Oslo, Oslo County, Norway

Carol Davila University of Medicine and Pharmacy

Bucharest, Romania

The Department of Cardiology at the Ljubljana University Medical Centre

Ljubljana, Slovenia

Yonsei University College of Medicine

Seoul, Seoul, South Korea

Department of Cardiovascular Sciences, University of Birmingham

Birmingham, United Kingdom

King's College

London, United Kingdom